XML 8 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Document and Entity Information - shares
 6 Months Ended
Dec. 31, 2025
Feb. 13, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Amendment Flag false  
Document Period End Date Dec. 31, 2025  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Entity Registrant Name Neuphoria Therapeutics Inc.  
Entity Central Index Key 0001191070  
Securities Act File Number 001-41157  
Entity Tax Identification Number 99-3845449  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --06-30  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Bankruptcy Proceedings, Reporting Current true  
Entity Address, Address Line One 100 Summit Drive  
Entity Address, City or Town Burlington  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01803  
City Area Code 781  
Local Phone Number 730-6665  
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol NEUP  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   5,390,895